References
- Matsunaga K Suzuki M Matsumoto N Stricter control of alanine transaminase by long-term administration of glycyrrhizin counters the disease progression in patients with chronic hepatitis C J St Marianna Univ 2012 3 1 23 33
- Acharya SK Sreenivas V Datta GS Treatment of chronic hepatitis due to hepatitis C virus (CH-C) in India: a randomized controlled trial comparing daily interferon-alfa-2b and ribavirin with daily interferon-alfa-2b and glycyrrhizin – a multicenter study J Clin Exp Hepatol 2012 2 1 10 18
- Ashfaq UA Nawaz Z Riazuddin S Glycyrrhizin as antiviral agent against hepatitis C virus J Transl Med 2011 9 112 21762538
- Ikeda K Glycyrrhizin injection therapy prevents hepatocellular carcinogenesis in patients with interferon-resistant active chronic hepatitis C Hepatol Res 2007 37 Suppl 2 S287 S293 17877497
- Sasaki K Yonebayashi S Yoshida M Shimizu K Aotsuka T Takayama K Improvement in the bioavailability of poorly absorbed glycyrrhizin via various non-vascular administration routes in rats Int J Pharm 2003 265 1–2 95 102 14522122
- Shibata N Ohno T Shimokawa T Application of pressure-controlled colon delivery capsule to oral administration of glycyrrhizin in dogs J Pharm Pharmacol 2001 53 4 441 447 11341360
- Koga K Kawashima S Shibata N Takada K Murakami M Preparation and rectal absorption of highly concentrated glycyrrhizin solution Biol Pharm Bull 2003 26 9 1299 1305 12951475
- Koga K Kawashima S Shibata N Takada K Novel formulations of a liver protection drug glycyrrhizin Yakugaku Zasshi 2007 127 7 1103 1114 17603270
- Koga K Nishimon Y Ueta H Matsuno K Takada K Utility of nano-sized, water-in-oil emulsion as a sustained release formulation of glycyrrhizin Biol Pharm Bull 2011 34 2 300 305 21415545
- Yamaoka K Tanigawara Y Nakagawa T Uno T A pharmacokinetic analysis program (MULTI) for microcomputer J Pharmacobiodyn 1981 4 11 879 885 7328489
- Ichikawa T Ishida S Sakiya Y Sawada Y Hanano M Biliary excretion and enterohepatic cycling of glycyrrhizin in rats J Pharm Sci 1986 75 7 672 675 3761168
- Ishida S Sakiya Y Ichikawa T Taira Z Awazu S Prediction of glycyrrhizin disposition in rat and man by a physiologically based pharmacokinetic model Chem Pharm Bull 1990 38 1 212 218 2337943
- Horikawa M Kato Y Tyson CA Sugiyama Y The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites Drug Metab Pharmacokinet 2002 17 1 23 33 15618649
- Shimamura H Suzuki H Tagaya O Horie T Sugiyama Y Biliary excretion of glycyrrhizin in rats: kinetic basis for multiplicity in bile canalicular transport of organic anions Pharm Res 1996 13 12 1833 1837 8987080
- Koga K Tomoyama M Ohyanagi K Takada K Pharmacokinetics of glycyrrhizin in normal and albumin-deficient rats Biopharm Drug Dispos 2008 29 7 373 381 18548521
- Imai T Hydrolysis by carboxylesterase and disposition of prodrug with ester moiety Yakugaku Zasshi 2007 127 4 611 619 17409690
- Shibata N Shimokawa T Jiang Z Characteristics of intestinal absorption and disposition of glycyrrhizin in mice Biopharm Drug Dispos 2000 21 3 95 101 11113882